ARTICLE | Management Tracks
Biohaven names Coric chair, Buten CFO
Plus: Mutamba joins Arrakis as CBO and updates from Goldfinch, Kymera, AnHeart and more
December 7, 2021 2:38 AM UTC
Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) appointed CEO Vlad Coric as chairman, following the retirement of Declan Doogan. The company also hired Matthew Buten as CFO, effective by Dec. 20, following the retirement of James Engelhart. Buten previously served as a healthcare portfolio manager at Catapult/Millennium Partners, and co-founded the healthcare funds Sapphire Capital and Argus Partners.
Arrakis Therapeutics Inc. hired James Mutamba as chief business officer. Mutamba was previously VP at Pyxis Oncology Inc. (NASDAQ:PYXS). Arrakis is developing small molecule medicines that directly target RNA. ...